SMi’s Biomarkers in Clinical Trials conference will present attendees with new concepts in biomarker application as well as a comprehensive review of recent developments. This unique event will bring together academics and industry professionals in order to provide a complete picture. There will be a strong focus on using biomarkers to bridge the gap between basic and applied research in drug development. There will also be a half-day post-conference workshop on Commercialisation of Biomarkers for Personalised Medicine. This interactive event will use examples and case studies to present participants with the opportunity to deal with the problems that they face or expect to face when defining their own biomarker commercialisation strategies.   View the conference programme   Register for the event   Download a brochure

Why should you attend this event?

Presentations will contain examples of biomarker application in the development of treatments for conditions in different therapeutic areas including oncology, nephrology, neurology and cardiology. Attendees will have the opportunity to network with industry associates and discuss the way forward in translational research and personalised medicine.

Hear keynote addresses from:

• Mark Fidock, Associate Director, Pfizer
• Shawnmarie Mayrand-Chung, National Institutes of Health Program Director, Biomarkers Consortium

Our expert speaker line-up also includes:

Chris Harbron, Technical Lead Statistician, Discovery Statistics, AstraZeneca David Dow, Group Leader, Molecular and Cellular Technologies, GlaxoSmithKline Alison Banham, Senior Scientist, Nuffield Department of Clinical Laboratory Sciences, University of Oxford Mike Lau, Principal Clinical Development Scientist, Oncology, GlaxoSmithKline Sterghios Moschos, Principle Scientist, Pfizer Russell D. Petty, Clinical Senior Lecturer in Medical Oncology, University of Aberdeen  Ansar Jawaid, Global Diagnostics Brand Manager, AstraZeneca Shethah Morgan, Senior Clinical Research Scientist, AstraZeneca Dominic Williams, Senior Lecturer, MRC Centre for Drug Safety Science, University of Liverpool

Who should attend?

Vice Presidents, Heads, Directors, Scientists and Project Leaders of:

Venue details

VENUE INFORMATION – Hilton London Kensington

179 – 199 Holland Park Avenue
London W11 4UL
Tel: +44 (0) 20 7603 3355
Fax: +44 (0) 20 7602 9397

     Bordering Notting Hill, in the exclusive West London residential area of Holland Park, the Hilton London Kensington is superbly located along the elegant tree-lined avenue of Holland Park, offering easy access to the West End.

DIRECTIONS

Driving & Parking
From the M40 via the M41 or from the M4 via Hammersmith and Shepherd’s bush. Exit the M41 and turn left at the roundabout onto Holland Park Avenue. The hotel is on the right,.
There is a car park located underneath the hotel, the car parking has 100 spaces. Please note that there is a reduced charge for residents (GBP15.00 per 24 hours) and that the company who runs it operates a first come first served policy.

By Underground
Holland Park is the nearest tube station on the Central Line. As you leave the station turn right and the hotel is approximately 7 minutes down this road on the left hand side.

By Train
Heathrow to Paddington Station, 20 minutes on the Heathrow Express Train (2 – 4 trains per hour) Gatwick to Victoria Station, 30 minutes by Gatwick Express Train (2 – 4 trains per hour) Take Underground to Holland Park Tube Station

If you wish to book accommodation at the Hilton London Kensington, SMi personnel can make the booking on your behalf at SMi’s discounted rate for this hotel or any of the hotels listed on the following page. Simply contact us for the rates & return the completed booking form.

SMi’s LONDON HOTEL RESERVATION SERVICE
It really couldn’t be easier - simply complete the form below and return it on the following fax number
or email address and we’ll take care of the rest:

Fax: +44 (0)207 827 6001       hotels@smi-online.co.uk

Conference Documentation